Fabtech Technologies IPO
Fabtech Technologies Limited
Minimum investment
Fabtech Technologies IPO Details
Bidding date
29 Sep - 01 Oct 2025
Price range
₹181 - ₹191
Minimum quantity
75
Minimum investment
₹13,575
Issue size
₹230.35 Cr.
IPO doc (link)
RHP docs
Listing exchange
NSE/BSE
Fabtech Technologies IPO Dates & Timeline
Fabtech Technologies IPO Subscription Status
Category | Subscription |
|---|---|
Qualified Institutional Buyers | 1.8x |
Retail Individual Investor | 0.93x |
Non-Institutional Investor | 0.85x |
Others | - |
Total | 0.93x |
About Fabtech Technologies IPO: Company Overview
Fabtech Technologies Ltd, incorporated in 2018, is a biopharma engineering company that specializes in turnkey projects and integrated engineering solutions. The company provides end-to-end services such as design, engineering, manufacturing, installation, and project management.
Fabtech is well-known for its expertise in cleanroom technology, HVAC systems, and process equipment, catering to global clients across life sciences, food & beverages, IT, semiconductors, and aeronautics industries. Its offerings include clean water solutions, clean air systems, modular facilities, and project execution with compliance to international standards.
As of July 31, 2025, the company had 185 permanent employees.
Strengths & Risks of Fabtech Technologies IPO
Leading Turnkey Biopharma Engineering Provider: Fabtech Technologies has established itself as a key turnkey solution provider in the biopharma engineering space, offering comprehensive services from design to execution.
Strong In-house Technology Capabilities: The company has in-house software and engineering expertise, which enhances efficiency and reduces dependency on external resources.
Diversified Order Book: Fabtech serves multiple industries and geographies, ensuring a well-balanced and risk-mitigated order book across clients and verticals.
Efficient Project Execution: With proven expertise in executing projects across challenging environments, the company has developed strong mandate conversion capabilities.
Consistent Financial Growth: The company has shown steady growth with robust financial metrics, including a Return on Equity (ROE) of 30.46% and Return on Capital Employed (ROCE) of 24.46%.
Sector Dependency: A large portion of Fabtech’s business is concentrated in the biopharma and life sciences sector, making it vulnerable to industry-specific fluctuations.
High Working Capital Needs: The business model requires significant working capital, which may affect liquidity and operational flexibility.
Rising Borrowings: The company’s borrowings increased sharply from Rs. 9.88 crore in FY24 to Rs. 54.62 crore in FY25, indicating higher financial leverage.
Earnings Dilution Post-Issue: The EPS is expected to decline from Rs. 14.34 pre-issue to Rs. 10.45 post-issue due to equity dilution, impacting shareholder value.
Regulatory Compliance Risk: As Fabtech operates globally, any non-compliance with international regulatory standards could disrupt business operations and affect growth.
Fabtech Technologies Financials: Revenue, Profit & EBITDA
N/A
N/A
N/A
How to Apply for Fabtech Technologies IPO: Step-by-Step Guide
- Research the IPO:Review the prospectus and company details.
- Open accounts:Ensure you have a demat and trading account.
- Check dates:Note the IPO opening and closing dates.
- Apply online:Log in to your brokerage account and complete the IPO application form.
- Make payment:Pay through your linked bank account.
- Submit application:Confirm and submit your application.
- Track status:Monitor the allotment status and check for shares in your demat account upon listing.
FAQs: Fabtech Technologies IPO
